SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 9, 2026

TRDA

Entrada Therapeutics, Inc.
BEARISH
Impact 6/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $547K total
Actionable Insight ▼ Bearish

The largest shareholder group is systematically reducing its stake with no insider buying to counterbalance. Monitor for additional MPM sales in coming weeks and any catalyst that might explain the exit, upcoming pipeline data or partnership news could be the driver. The selling is material enough to pressure the stock near-term.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$6.42
T+0 close · Sep 9, 2026 · via day close
Latest settled
−13.86%
T+20 · $5.53 · next T+60 in 17d
Vs SPY
−15.99%
α at T+20
Latest observation
+10.47%
T+46 · FF3 residual α
  1. T+0 · Sep 10 $6.42entry
  2. T+1 · 2mo ago +5.92%α +5.07% · $6.80
  3. T+5 · 2mo ago +7.48%α +7.98% · $6.90
  4. T+20 · 6w ago −13.86%α −15.99% · $5.53
  5. T+47 · todayOpen
  6. T+60 · in 17d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two MPM BioVentures funds (10% owners) sold a combined $547K in TRDA shares over two days, part of a larger 7-day cluster totaling $3.8M. The selling is concentrated at the largest shareholder level, not C-suite, and represents ~1.3% of market cap, a material reduction by a single insider group. No insider buying offsets this, and the pattern suggests systematic portfolio reduction rather than opportunistic timing.

Key Financial Metrics

Direction
selling
Total Value
$547.0K
Insiders
2

Key Facts

  • MPM BioVentures 2014 and 2018 funds sold 77,000 shares combined at $7.11 on 2026-09-04, totaling $547K
  • The same funds sold an additional $3.26M in TRDA on 2026-09-08 and 2026-09-09, bringing the 7-day cluster to $3.8M
  • Total 7-day selling represents ~1.3% of TRDA's $293M market cap
  • No insider purchases were reported in the cluster
  • All sales are open-market (Code S), not tax-withholding or derivative exercises

Financial Impact

$3.8M in open-market sales over 7 days, ~1.3% of market cap

dilutionownership concentration

Risk Factors

  • Continued selling by MPM BioVentures could further pressure the stock
  • No insider buying suggests management/board are not stepping in to signal confidence
  • Large shareholder exit may indicate negative non-public information about pipeline or financials

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TRDA-1788999611457

Track record

21 reports on TRDA

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +58.22% at T+20 after the May 4, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Neutral 4/10 No price data
  2. Nov 5, 202611d ago Press Release Neutral 4/10 Entry $4.55 Now $5.00 +9.89% settles Feb 3
  3. Oct 14, 20264w ago 8-K Bullish 6/10 Entry $4.55 Now $5.00 +9.89% settles Jan 11
  4. Sep 9, 20269w ago Insider Cluster Bearish 6/10 Viewing Entry $6.42 Now $5.00 +22.12% settles Dec 4
  5. Sep 3, 202610w ago Insider Cluster Neutral 3/10 Entry $7.13 Now $5.00 −29.87% settles Dec 1
  6. Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
  7. Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
  8. Aug 31, 202611w ago Insider Cluster Neutral 3/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
  9. Aug 26, 202611w ago Insider Cluster Neutral 3/10 Entry $7.27 Now $5.00 −31.22% settles Nov 20
  10. Aug 10, 202614w ago Insider Cluster Neutral 2/10 Entry $7.04 to $5.06 Now $5.00 −28.98% ▼ −28.13% −27.64% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 9, 2026